Joe Ciaffoni, Collegium Pharmaceutical CEO (via Collegium website)
Small pain drug player gets snapped up in $604M buyout — and the axe will soon fall
The small pain therapy player BioDelivery Sciences is getting scooped up in a $604 million buyout.
Collegium Pharmaceutical, a somewhat larger player in the pain …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.